NeoGenomics Inc (NEO) is a Healthcare · Diagnostics & Research company listed on NASDAQ. Price $19.89 (+5.02%), Market cap $1.09B, 52-week low–high $4.84 ~ $13.22.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging t
Financial statements, price targets, institutional (13F) holdings and related news for NeoGenomics Inc are updated in real time on BlackAll Trade.
NeoGenomics Inc trades at $19.89 (+5.02%). Real-time quotes and charts are available on BlackAll Trade.
NeoGenomics Inc has a market cap of about $1.09B.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologist